» Articles » PMID: 22339929

Clinical-histological Associations in Gastroparesis: Results from the Gastroparesis Clinical Research Consortium

Abstract

Background: Cellular changes associated with diabetic (DG) and idiopathic gastroparesis (IG) have recently been described from patients enrolled in the Gastroparesis Clinical Research Consortium. The association of these cellular changes with gastroparesis symptoms and gastric emptying is unknown. The aim of this study was to relate cellular changes to symptoms and gastric emptying in patients with gastroparesis.

Methods: Earlier, using full thickness gastric body biopsies from 20 DG, 20 IG, and 20 matched controls, we found decreased interstitial cells of Cajal (ICC) and enteric nerves and an increase in immune cells in both DG and IG. Here, demographic, symptoms [gastroparesis cardinal symptom index score (GCSI)], and gastric emptying were related to cellular alterations using Pearson's correlation coefficients.

Key Results: Interstitial cells of Cajal counts inversely correlated with 4 h gastric retention in DG but not in IG (r = -0.6, P = 0.008, DG, r = 0.2, P = 0.4, IG). There was also a significant correlation between loss of ICC and enteric nerves in DG but not in IG (r = 0.5, P = 0.03 for DG, r = 0.3, P = 0.16, IG). Idiopathic gastroparesis with a myenteric immune infiltrate scored higher on the average GCSI (3.6 ± 0.7 vs 2.7 ± 0.9, P = 0.05) and nausea score (3.8 ± 0.9 vs 2.6 ± 1.0, P = 0.02) as compared to those without an infiltrate.

Conclusions & Inferences: In DG, loss of ICC is associated with delayed gastric emptying. Interstitial cells of Cajal or enteric nerve loss did not correlate with symptom severity. Overall clinical severity and nausea in IG is associated with a myenteric immune infiltrate. Thus, full thickness gastric biopsies can help define specific cellular abnormalities in gastroparesis, some of which are associated with physiological and clinical characteristics of gastroparesis.

Citing Articles

A Standardized Classification Scheme for Gastroduodenal Disorder Evaluation Using the Gastric Alimetry System: Prospective Cohort Study.

Varghese C, Schamberg G, Uren E, Calder S, Law M, Foong D Gastro Hep Adv. 2025; 4(1):100547.

PMID: 39802489 PMC: 11719321. DOI: 10.1016/j.gastha.2024.09.002.


Faecal microbiota transplantation for patients with diabetes type 1 and severe gastrointestinal neuropathy (FADIGAS): a randomised, double-blinded, placebo-controlled trial.

Hoyer K, Dahl Baunwall S, Kornum D, Klinge M, Drewes A, Yderstraede K EClinicalMedicine. 2025; 79():103000.

PMID: 39791110 PMC: 11714726. DOI: 10.1016/j.eclinm.2024.103000.


Electrogastrography in Adult Gastroparesis: A Systematic Review and Meta-Analysis.

Peralta-Palmezano J, Escobar-Serna D, Peralta-Palmezano F, Acosta-Murillo N, Guerrero-Lozano R Dig Dis Sci. 2024; 70(1):298-315.

PMID: 39604665 PMC: 11761989. DOI: 10.1007/s10620-024-08727-9.


Sustained Effectiveness and Safety of Therapeutic miR-10a/b in Alleviating Diabetes and Gastrointestinal Dysmotility without Inducing Cancer or Inflammation in Murine Liver and Colon.

Singh R, Ha S, Park H, Debnath S, Cho H, Baek G Int J Mol Sci. 2024; 25(4).

PMID: 38396943 PMC: 10888952. DOI: 10.3390/ijms25042266.


Single cell atlas of human gastric muscle immune cells and macrophage-driven changes in idiopathic gastroparesis.

Chikkamenahalli L, Jessen E, Bernard C, Ip W, Breen-Lyles M, Cipriani G iScience. 2024; 27(3):108991.

PMID: 38384852 PMC: 10879712. DOI: 10.1016/j.isci.2024.108991.


References
1.
Samsom M, Bharucha A, Gerich J, Herrmann K, Limmer J, Linke R . Diabetes mellitus and gastric emptying: questions and issues in clinical practice. Diabetes Metab Res Rev. 2009; 25(6):502-14. DOI: 10.1002/dmrr.974. View

2.
Plourde V, Quintero E, Suto G, Coimbra C, Tache Y . Delayed gastric emptying induced by inhibitors of nitric oxide synthase in rats. Eur J Pharmacol. 1994; 256(2):125-9. DOI: 10.1016/0014-2999(94)90236-4. View

3.
Zarate N, Mearin F, Wang X, Hewlett B, Huizinga J, Malagelada J . Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: pathological findings and management. Gut. 2003; 52(7):966-70. PMC: 1773724. DOI: 10.1136/gut.52.7.966. View

4.
Kashyap P, Farrugia G . Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years. Gut. 2010; 59(12):1716-26. PMC: 2996823. DOI: 10.1136/gut.2009.199703. View

5.
Harberson J, Thomas R, Harbison S, Parkman H . Gastric neuromuscular pathology in gastroparesis: analysis of full-thickness antral biopsies. Dig Dis Sci. 2009; 55(2):359-70. DOI: 10.1007/s10620-009-1071-2. View